Peter Caravan

This inventor holds 17 USPTO granted patents and 11 published patent applications, plus 1 CIPO patent and 2 EPO patents, primarily in Magnetic Resonance Imaging. Top assignees: The General Hospital Corporation, Collagen Medical, LLC, Epix Pharmaceuticals, Inc.. Active years: 2003-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Peter Caravan. Retrieved from https://idiyas.com/inventor/peter-caravan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 17 (Patent Applications = 11)

% Patents Active = 88.2

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 2 (Patent Applications = 6)

Average Co-Inventor Count = 2.7

ph-index = 5

Forward Citations = 87(Granted Patents)

Company Filing History:

8 out of 3,085

The General Hospital Corporation

patents

3 out of 3

Collagen Medical, LLC

patents

2 out of 14

Epix Pharmaceuticals, Inc.

Siemens Healthcare Gmbh

where one patent can have more than one assignee

Years Active: 2003-2022

Loading Chart...

Areas of Expertise:

Manganese-based Chelate

Molecular MR Imaging

Collagen Imaging

Fibrin-binding Probes

Magnetic Resonance Contrast

Multimodal Imaging

Targeted Contrast Agents

Optically Pure Isomers

Fiducial Markers

Vascular Imaging

Peptide-based Agents

Low Power Imaging

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11400171 - Manganese-based chelate conjugates for molecular MR imaging (2022-08-02),

2. 10835623 - Manganese-based chelate conjugates for molecular MR imaging (2020-11-17),

3. 10471163 - Activatable fibrin-binding probes (2019-11-12),

4. 10471162 - Collagen targeted imaging probes (2019-11-12),

5. 10301358 - Collagen imaging compositions (2019-05-28),

6. 10012709 - System for optimized low power MR imaging (2018-07-03),

7. 9944668 - Manganese-based magnetic resonance contrast agents (2018-04-17),

8. 9889213 - Multimodal imaging of fibrin (2018-02-13),

9. 9386938 - Methods for collagen imaging (2016-07-12),

10. 9200017 - Multimodal imaging of fibrin (2015-12-01),

11. 8798716 - Fiducial markers and related methods (2014-08-05),

12. 8048906 - Optically pure and enriched isomers of chelating ligands and contrast agents (2011-11-01),

13. 8034898 - Methods of collagen imaging (2011-10-11),

14. 7927581 - Peptide-based multimeric targeted contrast agents (2011-04-19),

15. 7412279 - Systems and methods for targeted magnetic resonance imaging of the vascular system (2008-08-12),

Title: The Innovative Journey of Peter Caravan

Introduction: Peter Caravan, a pioneering inventor based in Cambridge, MA, has made significant contributions to the field of biomedical engineering through his groundbreaking innovations.

Latest Patents: Peter Caravan holds several patents in the area of medical imaging technologies, including a recent patent for a novel method of enhancing MRI contrast agents for improved diagnostic accuracy.

Career Highlights: With a background in chemistry and bioengineering, Peter Caravan has dedicated his career to developing cutting-edge solutions for healthcare challenges. His work has been instrumental in advancing the capabilities of medical imaging techniques.

Collaborations: Throughout his career, Peter Caravan has collaborated with leading research institutions and pharmaceutical companies to further the development and commercialization of his inventions. His collaborative efforts have resulted in the successful translation of his ideas from concept to market.

Conclusion: Peter Caravan's innovative spirit and commitment to pushing the boundaries of medical technology have established him as a prominent figure in the field of biomedical engineering. His contributions continue to have a lasting impact on the healthcare industry, improving patient outcomes and advancing the field of medical imaging.

Profile summary based on public USPTO records.